Elevated Interleukin-9 Receptor Expression and Response to Interleukins-9 and -7 in Thymocytes during Radiation-Induced T-Cell Lymphomagenesis in B6C3F1 Mice

Journal of Cellular Physiology

Volumn 198, Issue 1, 2004, Pages 82-90

  Nishimura, Mayumi ^a   Kakinuma, Shizuko ^a   Yamamoto, Daisuke ^a,b   Kobayashi, Yoshiro ^b   Suzuki, Gen ^c   Sado, Toshihiko ^d   Shimada, Yoshiya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^d OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; LEUKEMOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RECEPTOR GENE; T CELL LYMPHOMA; T CELL LYMPHOMAGENESIS; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE;

ANIMALS; CELL SURVIVAL; FEMALE; INTERLEUKIN-7; INTERLEUKIN-9; LYMPHOMA, T-CELL; MICE; MICE, INBRED STRAINS; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TIME FACTORS;

EID: 1642515027     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10390     Document Type: Article

References (43)

1. Alileche A, Goldman CK, Waldmann TA. 2001. Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha. Biochem Biophys Res Commun 285:1302-1308.
2. Bonecchi R, Facchetti F, Dusi S, Luini W, Lissandrini D, Simmelink M, Locati M, Bernasconi S, Allavena P, Brandt E, Rossi F, Mantovani A, Sozzani S. 2000. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 164:3862-3869.
3. Boniver J, Humblet C, Defresne MP. 1989. Tumor necrosis factor and interferon gamma inhibit the development of radiation-induced thymic lymphomas in C57BL/Ka mice. Leukemia 3:611-613.
4. De Smedt M, Verhasselt B, Kerre T, Vanhecke D, Naessens E, Leclercq G, Renauld JC, Van Snick J, Plum J. 2000. Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development. J Immunol 164:1761-1767.
5. Dibirdik I, Langlie MC, Ledbetter JA, Tuel-Ahlgren L, Obuz V, Waddick KG, Gajl-Peczalska K, Schieven GL, Uckun FM. 1991. Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. Blood 78:564-570.
6. Digel W, Schmid M, Heil G, Conrad P, Gillis S, Porzsolt F. 1991. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood 78:753-759.
7. Farber E. 1984. Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature. Biochim Biophys Acta 738:171-180.
8. Greenberger J, Leif J, Crawford D, Anklesaria P, English D, Sakakeeny M, Rubin J, Pierce J, Shadduck R, FitzGerald TJ. 1992a. Humoral and cell surface interactions during gamma-irradiation leukemogenesis in vitro. Exp Hematol 20:92-102.
9. Greenberger JS, Sakakeeny MA, Leif J, Anklesaria P, Pierce JH, Shadduck RK. 1992b. Expression of M-CSF and its receptor (C-FMS) during factor-independent cell line evolution from hematopoietic progenitor cells cocultivated with gamma irradiated marrow stromal cell lines. Leukemia 6:626-633.
10. Gruss HJ, Brach MA, Drexler HG, Bross KJ, Herrmann F. 1992. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. Cancer Res 52:1026-1031.
11. Houssiau FA, Renauld JC, Stevens M, Lehmann F, Lethe B, Coulie PG, Van Snick J. 1993. Human T cell lines and clones respond to IL-9. J Immunol 150:2634-2640.
12. Hultner L, Moeller J. 1990 Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline. Exp Hematol 18:873-877.
13. Humblet C, Greimers R, Delvenne P, Deman J, Boniver J, Defresne MP. 1996. Prevention of murine radiogenic thymic lymphomas by tumor necrosis factor or by marrow grafting. J Natl Cancer Inst 88:824-831.
14. Humblet C, Greimers R, Boniver J, Defrense MP. 1997. Stages in the development of radiation-induced thymic lymphomas in C57 BL/Ka mice: Preleukemic cells become progressively resistant to the tumor preventing effects of a bone marrow graft. Exp Hematol 25:109-113.
15. Kamisaku H, Aizawa S, Kitagawa M, Ikarashi Y, Sado T. 1997. Limiting dilution analysis of T cell progenitors in the bone marrow of thymic lymphoma-susceptible B10 and -resistant C3H mice after fractionated whole-body X-irradiation. Int J Radiat Biol 72:191-199.
16. Karawajew L, Ruppert V, Wuchter C, Kosser A, Schrappe M, Dorken B, Ludwig WD. 2000. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T cell acute lymphoblastic leukemia. Blood 96:297-306.
17. Karen J, Wang Y, Javaherian A, Vaccariello M, Fusenig NE, Garlick JA. 1999. 12-O-tetradecanoylphorbol-13-acetate induces clonal expansion of potentially malignant keratinocytes in a tissue model of early neoplastic progression. Cancer Res 59:474-481.
18. Kubota S, Siomi H, Hatanaka M, Pomerantz RJ. 1996. Cis/transactivation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cell. Oncogene 12:1441-1447.
19. Masuda M, Takanashi M, Motoji T, Oshimi K, Mizoguchi H. 1991. Effects of interleukins 1-7 on the proliferation of T-lineage acute lymphoblastic leukemia cells. Leuk Res 15:1091-1096.
20. Metcalf D. 1994. Hemopoietic regulators and leukemia development: A personal retrospective. Adv Cancer Res 63:41-91.
21. Mizutani N, Fujikura Y, Wang YH, Tamechika M, Tokuda N, Sawada T, Fukumoto T. 2002. Inflammatory and anti-inflammatory cytokines regulate the recovery from sublethal X irradiation in rat thymus. Radiat Res 157:281-289.
22. Moser GJ, Wolf DC, Harden R, Standeven AM, Mills J, Jirtle RL, Goldsworthy TL. 1996. Cell proliferation and regulation of negative growth factors in mouse liver foci. Carcinogenesis 17:1835-1840.
23. Muto M, Kubo E, Kamisaku H, Sado T. 1990. Phenotypic characterization of thymic prelymphoma cells of B10 mice treated with split-dose irradiation. J Immunol 144:849-853.
24. Ohara J, Paul WE. 1988. Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression. Proc Natl Acad Sci USA 85:8221-8225.
25. Rabbitts TH. 1991. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67:641-644.
26. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
27. Rawstron AC, Fenton JA, Ashcroft J, English A, Jones RA, Richards SJ, Pratt G, Owen R, Davies FE, Child JA, Jack AS, Morgan G. 2000. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood 96:3880-3886.
28. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. 1980. Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T cell lineage. Proc Natl Acad Sci USA 77:1588-1592.
29. Renauld JC, Houssiau F, Louahed J, Vink A, Van Snick J, Uyttenhove C. 1993. Interleukin-9. Adv Immunol 54:79-97.
30. Renauld JC, van der Lugt N, Vink A, van Roon M, Godfraind C, Warnier G, Merz H, Feller A, Berns A, Van Snick J. 1994. Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 9:1327-1332.
31. Renauld JC, Vink A, Louahed J, Van Snick J. 1995. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85:1300-1305.
32. Rodewald HR, Fehling HJ. 1998. Molecular and cellular events in early thymocyte development. Adv Immunol 69:1-112.
33. Sado T, Kamisaku H, Kubo E. 1991. Bone marrow-thymus interactions during thymic lymphomagenesis induced by fractionated radiation exposure in B10 mice: Analysis using bone marrow transplantation between Thy 1 congenic mice. J Radiat Res (Tokyo) 32(Suppl 2):168-180.
34. Shimada Y, Nishimura M, Kakinuma S, Takeuchi T, Ogiu T, Suzuki G, Nakata Y, Sasanuma S, Mita K, Sado T. 2001. Characteristic association between K-ras gene mutation with loss of heterozygosity in X-ray-induced thymic lymphomas of the B6C3F1 mouse. Int J Radiat Biol 77:465-473.
35. Siegler R, Harrell W, Rich MA. 1966. Pathogenesis of radiation-induced thymic lymphoma in mice. J Natl Cancer Inst 37:105-121.
36. Stockert E, Old LJ. 1977. Preleukemic expression of TL antigens in x-irradiated C57BL/6 mice. J Exp Med 146:271-276.
37. Suda T, Murray R, Fischer M, Yokota T, Zlotnik A. 1990. Tumor necrosis factor-alpha and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2. J Immunol 144:1783-1787.
38. Tomeczkowski J, Frick D, Schwinzer B, Wittner N, Ludwig WD, Reiter A, Welte K, Sykora KW. 1998. Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells. Leukemia 12:1221-1229.
39. Touw I, Pouwels K, van Agthoven T, van Gurp R, Budel L, Hoogerbrugge H, Delwel R, Goodwin R, Namen A, Lowenberg B. 1990. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 75:2097-2101.
40. Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H. 1985. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 76:446-453.
41. Uyttenhove C, Simpson RJ, Van Snick J. 1988. Functional and structural characterization of P40, a mouse glycoprotein with T cell growth factor activity. Proc Natl Acad Sci USA 85:6934-6938.
42. Vink A, Renauld JC, Warnier G, Van Snick J. 1993. Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas. Eur J Immunol 23:1134-1138.
43. Zlotnik A, Moore TA. 1995. Cytokine production and requirements during T cell development. Curr Opin Immunol 7:206-213.